Literature DB >> 10783324

The effect of lithocholic acid on proliferation and apoptosis during the early stages of colon carcinogenesis: differential effect on apoptosis in the presence of a colon carcinogen.

V Kozoni1, G Tsioulias, S Shiff, B Rigas.   

Abstract

Lithocholic acid (LCA) is implicated in human and experimental animal carcinogenesis. Its effect on apoptosis and proliferation of the colonic epithelium was studied in a 1,2-dimethylhydrazine (DMH)-induced murine carcinogenesis model. Four groups of mice, control, LCA, DMH and DMH+LCA, were studied for 4 weeks, a period corresponding to early stages of carcinogenesis. Apoptosis (AI) and proliferation (PI) indices in the colon were determined by immunohistochemistry. LCA stimulated apoptosis [AI = 1.2 +/- 0.3% (all values are the mean +/- SEM) versus control 0.5 +/- 0.1%, P < 0. 05], as did DMH (4.3 +/- 0.8%, P < 0.02). DMH increased apoptosis at the base of the crypt nearly 50-fold, with no effect at the lumenal third. In mice receiving DMH, LCA suppressed apoptosis almost completely (0.1 +/- 0.03%); this suppression was complete at the lower two-thirds of the crypt (AI = 0) and 60% at the lumenal third. LCA increased proliferation (PI = 22.2 +/- 4.6% versus 15.4 +/- 1% in controls), but this did not reach statistical significance. DMH increased proliferation (PI = 34.6 +/- 2.3%, P < 0.01). In mice receiving DMH, proliferation (41 +/- 2.9%) was about two-thirds of the additive effect. LCA affected proliferation, mainly in the middle third of the crypt; DMH's effect was similar in distribution, but more pronounced. In mice receiving DMH, LCA shifts proliferation upward, extending it to the lumenal third of the crypt. LCA's main cell kinetic effect in the colon is on apoptosis; this effect differs in normal (stimulation) and pre-malignant colon (nearly complete suppression). LCA does not significantly stimulate proliferation in either normal or pre-malignant colon. The differential effect of LCA on apoptosis in the presence of a carcinogen partially explains its effect as a promoter on colon carcinogenesis in animal models, and may have important implications for human carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10783324     DOI: 10.1093/carcin/21.5.999

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  23 in total

1.  Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations.

Authors:  Junhai Ou; James P DeLany; Ming Zhang; Sumit Sharma; Stephen J D O'Keefe
Journal:  Nutr Cancer       Date:  2011-12-02       Impact factor: 2.900

2.  Phospho-sulindac (OXT-328) inhibits the growth of human lung cancer xenografts in mice: enhanced efficacy and mitochondria targeting by its formulation in solid lipid nanoparticles.

Authors:  Rongrong Zhu; Ka-Wing Cheng; Gerardo Mackenzie; Liqun Huang; Yu Sun; Gang Xie; Kveta Vrankova; Panayiotis P Constantinides; Basil Rigas
Journal:  Pharm Res       Date:  2012-06-22       Impact factor: 4.200

3.  When Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow?

Authors:  Noriko N Yokoyama; Andria Denmon; Edward M Uchio; Mark Jordan; Dan Mercola; Xiaolin Zi
Journal:  Curr Pharmacol Rep       Date:  2015-04-14

4.  Investigation of Musashi-1 expressing cells in the murine model of dextran sodium sulfate-induced colitis.

Authors:  Tadahisa Fukui; Hiroaki Takeda; Hong-Jin Shu; Katsuyoshi Ishihama; Sayaka Otake; Yasukuni Suzuki; Shoichi Nishise; Nanami Ito; Takeshi Sato; Hitoshi Togashi; Sumio Kawata
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

Review 5.  Obesity and cancer: A mechanistic overview of metabolic changes in obesity that impact genetic instability.

Authors:  Pallavi Kompella; Karen M Vasquez
Journal:  Mol Carcinog       Date:  2019-06-05       Impact factor: 4.784

6.  Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho.

Authors:  Shinji Ito; Toshihiko Fujimori; Akiko Furuya; Junko Satoh; Yoko Nabeshima; Yo-Ichi Nabeshima
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

7.  Regulation of apoptosis in HL-1 cardiomyocytes by phosphorylation of the receptor tyrosine kinase EphA2 and protection by lithocholic acid.

Authors:  J Jehle; I Staudacher; F Wiedmann; Pa Schweizer; R Becker; Ha Katus; D Thomas
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

8.  Evaluation of immunologic and intestinal effects in rats administered an E 171-containing diet, a food grade titanium dioxide (TiO2).

Authors:  Lance K Blevins; Robert B Crawford; Anthony Bach; Michael D Rizzo; Jiajun Zhou; Joseph E Henriquez; D M Isha Olive Khan; Sera Sermet; Lora L Arnold; Karen L Pennington; Nathalia P Souza; Samuel M Cohen; Norbert E Kaminski
Journal:  Food Chem Toxicol       Date:  2019-08-29       Impact factor: 6.023

9.  Switch from Mnt-Max to Myc-Max induces p53 and cyclin D1 expression and apoptosis during cholestasis in mouse and human hepatocytes.

Authors:  Heping Yang; Tony W H Li; Kwang Suk Ko; Meng Xia; Shelly C Lu
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

10.  The antiapoptotic role of pregnane X receptor in human colon cancer cells.

Authors:  Jie Zhou; Mingjie Liu; Yonggong Zhai; Wen Xie
Journal:  Mol Endocrinol       Date:  2007-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.